Forte Biosciences, Inc.
NASDAQ:FBRX · NASDAQ Capital Market
+$0.30 today
Vol 0.17M · Avg 0.30M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+39.89%
Period High
$35.53
Period Low
$9.45
Latest
$17.85
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Fate Therapeutics, Inc.
NASDAQ:FATE
$228.46M
Nkarta, Inc.
NASDAQ:NKTX
$195.68M
Alector, Inc.
NASDAQ:ALEC
$181.53M
Molecular Partners AG
NASDAQ:MOLN
$147.42M
PepGen Inc.
NASDAQ:PEPG
$123.81M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$101.88M
Cardiff Oncology, Inc.
NASDAQ:CRDF
$82.73M
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$72.15M
Actuate Therapeutics Inc
NASDAQ:ACTU
$51.20M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest FBRX filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does FBRX have?
Intrinsic Alpha currently shows 20 recent filings for FBRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.